×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
FDA Grants Fast Track Status for Neovacs' study of IFNα Kinoid in Lupus
Lupus Foundation of America
FDA Grants Fast Track Status for Neovacs' study of IFNα Kinoid in Lupus. The U.S. Food and Drug Administration (FDA) has granted Fast Track...
88 months ago
Pharnext Announces a €2.5m Loan Agreement with Néovacs
Yahoo Finance
Pharnext SA (FR0011191287-ALPHA) (the "Company"), an advanced late-clinical stage biopharmaceutical company developing novel therapeutics...
20 months ago
French Biotech Neovacs' Lupus Vaccine can Move Into Phase III
Labiotech.eu
Neovacs, a French biotech, obtained positive Phase IIb results showing its lupus vaccine could be effective in treating this severe...
69 months ago
A New Milestone in the Development of an Effective Allergic Asthma Vaccine - Inserm Newsroom
Salle de presse de l'Inserm
Microscopic visualization of lung sections from a mouse model of house dust mite asthma, with hematoxylin and eosin staining showing...
13 months ago
NEOVACS : VALIDATION OF THE "RESTARTED" PLAN BY THE PARIS COMMERCIAL COURT
sharewise
End of court-ordered receivership proceedings Continuation of core research in lupus and allergies Creation of a new business investing in...
47 months ago
Miguel Sieler, former Chairman and C.E.O. Bayer France, named C.E.O. of Neovacs
Business Wire
Neovacs is a biotechnology company focused on an active immunotherapy technology platform (Kinoids) with applications in autoimmune and/or...
126 months ago
Hugo Brugière Joins Pharnext Board of Directors
Yahoo Finance
Pharnext SA (FR0011191287 - ALPHA) (the "Company"), an advanced late-clinical stage biopharmaceutical company developing novel therapeutics...
17 months ago